Literature DB >> 381925

Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

E D Thomas, C D Buckner, R A Clift, A Fefer, F L Johnson, P E Neiman, G E Sale, J E Sanders, J W Singer, H Shulman, R Storb, P L Weiden.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 381925     DOI： 10.1056/NEJM197909133011109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  76 in total

Review 1.  Drug treatment of acute leukaemia. Current status.

Authors:  S M Donohue; C P Charlton
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 2.  Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care.

Authors:  Razvan Diaconescu; Rainer Storb
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-28       Impact factor: 4.553

Review 3.  Bone marrow transplantation from the personal viewpoint.

Authors:  E Donnall Thomas
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

4.  A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.

Authors:  Barbara Spitzer; Ann A Jakubowski; Esperanza B Papadopoulos; Kirsten Fuller; Patrick D Hilden; James W Young; Juliet N Barker; Guenther Koehne; Miguel-Angel Perales; Katharine C Hsu; Marcel R van den Brink; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Hugo Castro-Malaspina; Richard J O'Reilly; Farid Boulad
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-12       Impact factor: 5.742

5.  Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin.

Authors:  B Isberg; C Paul; L Jönsson; U Svahn
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W E Fibbe; W F Veenhof; A Brand; J H Falkenburg
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Liver disease after bone marrow transplantation.

Authors:  M J Farthing; M L Clark; J P Sloane; R L Powles; T J McElwain
Journal:  Gut       Date:  1982-06       Impact factor: 23.059

8.  Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.

Authors:  A Hagenbeek; A C Martens
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

9.  Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS.

Authors:  J De La Serna; J Sanz; A Bermúdez; M Cabrero; D Serrano; C Vallejo; V Gómez; J M Moraleda; S G Perez; M D Caballero; E Conde; J J Lahuerta; G Sanz
Journal:  Bone Marrow Transplant       Date:  2016-03-07       Impact factor: 5.483

10.  [Bone marrow transplantation in panmyelopathy, acute leukemia and chronic myelocytic leukemia: results of the Ulm Transplantation Group].

Authors:  R Arnold; T Schmeiser; W Friedrich; F Carbonell; S F Goldmann; W Heit; E Kohne; E Kurrle; E Röttinger; M Wannenmacher
Journal:  Klin Wochenschr       Date:  1984-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.